ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

April 10, 2009

Stand Up To Cancer Launches Immunology “Dream Team”

December 14, 2012

Community Clinical Oncology Program Renewed, NCI Hopes To Restore Cuts In ’08.

March 30, 2007

Will Latest Report By Rosenberg Stir Up Critics? Some DCT Board Members Defend the Press

April 10, 1987

Protein Patterns May Identify Ovarian Cancer Earlier

March 29, 2002

New Organ Systems Program Coordinating Center RFA Released

April 1, 1983